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The immune system affords protection 
from environmental pathogens, but this 
service comes at a price: uncontrolled 
responses can damage the host by caus-
ing immune pathology, and responses to 
self-antigens can result in autoimmunity.
T reg cells are therefore essential for a 
balanced  immune  system.  The  fork-
head–winged helix transcription factor 
Foxp3 coordinates the T reg cell gene 
expression  program,  and  its  absence 
causes death by lymphoproliferation and 
multiorgan  autoimmunity  in  humans 
with immunodysregulation, polyendo-
crinopathy,  and  enteropathy  X-linked 
syndrome and in Foxp3-deficient mice 
(Brunkow et al., 2001; Fontenot et al., 
2003; Khattri et al., 2003).
Intrathymically  induced  T  reg  (it-
Treg) cells are thought to arise by a two-
step  process,  in  which  TCR  signaling 
induces competence for Foxp3 expres-
sion and the expression of the high- 
affinity IL-2 receptor- chain (CD25). 
IL-2, or other cytokines that activate   
STAT5, then induce Foxp3 expression 
(Burchill  et al.,  2008;  Lio  and  Hsieh, 
2008;  Wirnsberger  et al.,  2009).  The 
contributions of TGF- to itTreg cell 
differentiation  (Liu  et al.,  2008)  and   
to the maintenance of functional T reg 
cells  in  peripheral  lymphoid  organs   
(Marie et al., 2005; Li et al., 2006; Pesu 
et al., 2008) remain to be fully elucidated. 
Runx transcription factors are involved 
in the induction and in the maintenance 
of Foxp3 expression (Bruno et al., 2009; 
Kitoh et al., 2009; Klunker et al., 2009; 
Rudra  et al.,  2009),  and  microRNAs 
contribute  to  both  the  development 
(Cobb et al., 2006) and the maintenance 
of T reg cells (Chong et al., 2008; Liston 
et al., 2008; Zhou et al., 2008).
Extrathymically  induced  T  reg 
(etTreg) cells can be formed in periph-
eral  lymphoid  organs  (Apostolou  and 
von Boehmer, 2004; Kretschmer et al., 
2005; Curotto de Lafaille and Lafaille, 
2009).  Although  the  physiological   
importance  of  etTreg  cells  is  much   
less  certain  than  that  of  itTreg  cells, 
etTreg cells have been intensely studied 
because  they  can  easily  be  generated   
in vitro and bear therapeutic promise. 
Major inducers of Foxp3 expression in 
peripheral T cells in vitro include TCR 
signaling  in  the  presence  of  TGF- 
(Chen  et al.,  2003),  the  downstream 
TGF-  signal  transducers  Smad2  and 
Smad3, and retinoic acid (Benson et al., 
2007;  Coombes  et al.,  2007;  Mucida 
et al., 2007; Sun et al., 2007). Genetic 
and pharmacological evidence indicates 
that  the  PI3K–Akt–mTOR  signaling 
network interferes with Foxp3 induction 
in vitro, as well as in vivo (Haxhinasto 
et al. 2008; Sauer et al., 2008; unpub-
lished data), but the mechanisms that 
link  PI3K–Akt–mTOR  signaling  to 
Foxp3  expression  have  until  recently 
been unknown.
Conserved noncoding sequences 
integrate signals influencing  
Foxp3 expression
Like other metazoan genes, the expres-
sion of Foxp3 is regulated by multiple 
transcription factors, by chromatin, and 
by cis-regulatory elements. TCR acti-
vation induces the binding of transcrip-
tion factors such as NFAT, AP1, CREB, 
and ATF to the Foxp3 promoter and 
enhancer elements (Kim and Leonard, 
2007; Tone et al., 2008). T reg cell   
development is impaired in T cells lack-
ing  signaling  molecules  needed  for   
NF-B activation (e.g., PKC-, Bcl10, 
CARMA1, and MALT1), and c-Rel is 
a  critical  NF-B  component  in  this 
context  (Isomura  et al.,  2009;  Long 
et al., 2009; Ruan et al., 2009; Zheng 
et al., 2010).
In addition to the promoter, at least 
three  conserved  noncoding  sequence 
(CNS) elements contribute to the regu-
lation  of  the  Foxp3  locus  (Kim  and 
Leonard,  2007;  Tone  et al.,  2008; 
Huehn et al., 2009; Zheng et al., 2010). 
Because the nomenclatures used in these 
studies differ, we will refer to these   
elements  by  their  position  relative  to   
the Foxp3 transcription start site (TSS; 
Fig. 1). Two CNS +2 kb and +4.5 kb 
in the 5 untranslated region (referred to 
Expression of the regulatory T (T reg) cell–associated transcription factor 
Foxp3 can be induced by signals from the T cell receptor (TCR), interleukin-2 
(IL-2), and transforming growth factor (TGF)-. These signals are integrated by 
a network involving phosphatidylinositol 3 kinase (PI3K), protein kinase B (PKB; 
here referred to as Akt), and the mammalian target of rapamycin (mTOR). New 
studies show that the Foxo proteins Foxo1 and Foxo3a, which are inactivated 
by Akt, drive Foxp3 expression. These studies therefore explain the negative 
regulation of Foxp3 by PI3K signaling, and add Foxo proteins to the growing 
list of nuclear factors capable of modulating Foxp3 expression.
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pathway connecting PI3K–Akt–mTOR 
to Foxp3.
In  agreement  with  previous  work 
(Wohlfert  et al.,  2006),  Harada  et al. 
(2010) found that Cbl-b–deficient CD4 
T cells expressed less Foxp3 in response 
to TGF- in vitro and in an adoptive 
transfer model in vivo. Cbl-b deficiency 
was thought to impair cellular responses 
to TGF- by affecting Smad2 phosphory-
lation  (Wohlfert  et al.,  2006).  Surpris-
ingly, Harada et al. (2010) found intact 
TGF- responses in Cbl-b–deficient CD4   
T cells. Instead, they analyzed Foxo tran-
scription factors, which have important 
functions in the homeostasis of the im-
mune system (Hedrick, 2009). The ac-
tivity  of  Foxo  proteins  is  regulated  at 
multiple levels, most strikingly by Akt-
mediated phosphorylation. Phosphoryla-
tion by Akt inactivates Foxo proteins by 
excluding them from the nucleus. In this 
way, Foxo localization reflects PI3K sig-
naling (Hedrick, 2009). The link to Cbl-b   
is  previous  work  showing  that  Cbl-b 
promotes  ubiquitinylation  of  p85,  the 
regulatory subunit of PI3K, and thereby 
affects the activity of Akt (Fang and Liu, 
2001). Consistent with increased PI3K–
Akt signaling in Cbl-b–deficient T cells, 
Harada  et al.  (2010)  noted  increased 
phosphorylation  of  Foxo3a  in  Cbl-b– 
deficient CD4 T cells. Foxo3a-deficient 
CD4 T cells showed reduced Foxp3 in-
duction in response to TGF-. In con-
trast,  deletion  of  Foxo3a  did  not  have   
any effect on the numbers of Foxp3- 
expressing  itTreg  cells  (Harada  et al., 
2010), suggesting a preferential involve-
ment of Foxo3a in etTreg cell, as op-
posed to itTreg cell differentiation. This 
is consistent with observations showing 
that the increased PI3K signaling that re-
sults from the loss of Cbl-b impaired in-
ducible Foxp3 expression, but did not 
substantially impact itTreg cell numbers 
(Wohlfert et al., 2006). However, both 
inducible  and  itTreg  differentiation 
were  affected  by  constitutively  active 
Akt (Haxhinasto et al., 2008).
Ouyang  et al.  (2010)  demonstrate 
that  the  apparently  selective  require-
ment of Foxo3a for Foxp3 induction in 
etTreg cells is caused, at least in part, by 
redundancy between Foxo3a and Foxo1. 
Consistent with the finding that the loss 
of  methyltransferase  enzymes  leads  to 
stable Foxp3 expression (Huehn et al., 
2009). Loss of DNA methylation pro-
motes the binding to the CNS at +4.5 kb 
of the transcription factors CREB, ATF 
(Kim and Leonard, 2007), the NF-B 
component  c-Rel  (Long  et al.,  2009), 
Runx–Cbfb (Bruno et al., 2009; Rudra 
et al.,  2009),  and,  interestingly,  Foxp3 
itself. Hence, the CNS at +4.5 kb could 
form part of a positive feedback loop,   
by which Foxp3 maintains its own expres-
sion (Zheng et al., 2010).
Foxos link PI3K–Akt–mTOR to Foxp3
Efficient Foxp3 induction requires pro-
teins that limit PI3K activity, such as 
Cbl-b (Wohlfert et al., 2006) and PTEN 
(Sauer et al., 2008). Conversely, consti-
tutive Akt activity interferes with Foxp3 
induction  (Haxhinasto  et al.,  2008). 
mTORC2 activates Akt by phosphory-
lating it on Ser473, and loss or inhibition 
of mTORC2 inactivates Akt and con-
sequently promotes Foxp3 induction   
(Delgoffe et al., 2009). Harada et al. (this 
issue) and Ouyang et al. (2010) now   
align Foxo1 and Foxo3a in the signaling 
as CNS2 and 3 in Tone et al., 2008 and 
Kim and Leonard, 2007, and as CNS1 
and 2 in Zheng et al., 2010). A further 
CNS is at +7 kb, just downstream of the 
first coding exon (CNS3 in Zheng et al., 
2010). The CNS at +7 kb plays a role in 
itTreg and etTreg cells, as its deletion re-
duces the frequency of T reg cells gener-
ated in the thymus and in the periphery 
(Zheng  et al.,  2010).  In  contrast,  the 
CNS at +2 kb is not required for itTreg 
cell differentiation. Consistent with a 
role  in  inducible  Foxp3  expression 
(Zheng et al., 2010), this CNS contains 
binding sites for NFAT, an effector of 
TCR signaling, and for SMAD proteins, 
which mediate TGF- signaling (Kim 
and Leonard, 2007; Tone et al., 2008; 
Zheng et al., 2010). Finally, the CNS at 
+4.5  kb  is  important  for  the  mainte-
nance,  rather  than  the  induction,  of 
Foxp3 expression (Zheng et al., 2010). 
This CNS contains a region rich in CpG 
dinucleotides, the targets for mammalian 
DNA methylation, and is methylated in 
conventional T cells and demethylated 
in  itTreg  cells.  Demethylation  of  this   
region by inhibition or genetic deletion 
Figure 1.  Signals, factors, and regulatory elements that control Foxp3 expression. The figure 
shows the 5 part of the mouse Foxp3 locus, as well as signals and factors known to regulate its 
expression. Conservation is indicated in blue as a track from the University of California Santa Cruz 
Genome Browser (http://genome.ucsc.edu; Rhead et al., 2010). Conserved noncoding sequences with 
known functions are indicated in red. Black rectangles indicate exons (open for noncoding, filled for 
coding). TSS indicates the transcription start site.JEM VOL. 207, July 5, 2010 1349
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indicate the functional importance of a 
site close to the Foxp3 transcription start 
site (Harada et al., 2010; Ouyang et al., 
2010). In light of these data, which sug-
gest a role for Foxo proteins in the regu-
lation of Foxp3, it is puzzling that Foxp3 
expression  was  apparently  normal  in 
Foxo1
/Foxo3a
/ splenic T reg cells 
(Ouyang et al., 2010).
Conclusions
The  emerging  scenario  is  that  PI3K–
Akt–mTOR signaling prevents the in-
duction, but does not interfere with the 
maintenance,  of  Foxp3  expression  via 
Foxo factors. It is therefore likely that 
with Foxo1 and Foxo3a, Harada et al. 
(2010)  and  Ouyang  et al.  (2010)  have 
identified  a  molecular  link  between 
PI3K–Akt–mTOR signaling and Foxp3 
induction. Time will tell if there are 
other  negative  regulators  of  Foxp3   
expression  downstream  of  PI3K–Akt–
mTOR signaling.
Given  the  promise  of  inducible 
Foxp3 expression in the immunotherapy 
of autoimmunity and immune pathol-
ogy (Daniel et al., 2009), Foxo factors, 
especially the kinases that control their 
activity, represent potential drug targets 
(Bruno and Merkenschlager, 2008).
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